Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 2/20 | 0.34 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA7 | P43166 | 2/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SYK | P43405 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8785206 | 0.84 | ZDHHC7 (0.39) | ZDHHC7CTSSCTSKKMT2ALMNA | |
| SCHEMBL9352351 | 0.84 | KMT2A (0.33) | ZDHHC7CTSSCTSKKMT2ALMNA | |
| SCHEMBL9691868 | 0.83 | ZDHHC7 (0.44) | ZDHHC7CTSSCTSKKMT2ACA1 | |
| SCHEMBL5326517 | 0.83 | ZDHHC7 (0.32) | ZDHHC7KMT2AALDH1A1CA1CA2 | |
| SCHEMBL6337940 | 0.82 | ALDH1A1 (0.42) | ZDHHC7CTSSCTSKKMT2ALMNA | |
| SCHEMBL3205535 | 0.80 | NOS1 (0.34) | KMT2ALMNACA1CA2CA7 | |
| SCHEMBL2007637 | 0.79 | ZDHHC7 (0.55) | ZDHHC7CTSSCTSKCA1CA2 | |
| SCHEMBL7329329 | 0.79 | ZDHHC7 (0.55) | ZDHHC7CTSSCTSKCA1CA2 | |
| SCHEMBL2536122 | 0.79 | CTSS (0.35) | CTSSCTSKKMT2ALMNAALDH1A1 | |
| SCHEMBL4385861 | 0.78 | CA1 (0.38) | CTSSCTSKKMT2AALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 233 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113087312-B | Chemical wastewater treatment process based on PSF-g-CS polymer microfiltration membrane | 河南鑫安利职业健康科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-113087312-A | Chemical wastewater treatment process based on PSF-g-CS polymer microfiltration membrane | 河南鑫安利职业健康科技有限公司 | 2021-07-09 | — | — | CN | claimed |
| EP-2427415-B1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | BASF AS (NO) | 2019-03-20 | — | — | EP | claimed |
| CN-105884676-B | The preparation method of fullerene-polyoxometallate hybrid molecule | 中国科学院兰州化学物理研究所 | 2018-06-29 | — | — | CN | claimed |
| CN-102459142-B | For treating the polyunsaturated fatty acid to disease cardiovascular, that metabolism is related with inflammatory disease field | 普罗诺瓦生物医药挪威公司 | 2017-08-08 | — | — | CN | claimed |
| CN-105884676-A | Preparation method of fullerenes-polyoxometalates hybrid molecules | 中国科学院兰州化学物理研究所 | 2016-08-24 | — | — | CN | claimed |
| US-8735436-B2 | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-05-27 | — | — | US | claimed |
| US-20120122940-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | PRONOVA BIOPHARMA NORGE AS (NO) | 2012-05-17 | — | — | US | claimed |
| CN-102459142-A | Polyunsaturated fatty acids for the treatment of diseases related to the cardiovascular, metabolic and inflammatory disease fields | PRONOVA BIOPHARMA NORGE AS | 2012-05-16 | — | — | CN | claimed |
| WO-2026104409-A1 | MULTIMERIC MANGANESE CONTRAST AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2026-05-21 | — | — | WO | disclosed |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260000632-A1 | STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE | NORTHSEA THERAPEUTICS B V (NL) | 2026-01-01 | — | — | US | disclosed |
| US-12440466-B2 | Fatty acid derivatives for treating non-alcoholic steatohepatitis | BASF AS (NO) | 2025-10-14 | — | — | US | disclosed |
| US-12358925-B2 | Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) | 2025-07-15 | — | — | US | disclosed |
| CN-1233256-A | Dipeptide benzamidine as a kininogenase inhibitor | BASF AG (DE) | 1999-10-27 | — | — | CN | disclosed |
| US-5587514-A | Diastereoselective synthesis of hydroxyethylene dipeptide isosteres | EMORY UNIVERSITY (US) | 1996-12-24 | — | — | US | disclosed |
| WO-1995014655-A1 | DIASTEREOSELECTIVE SYNTHESIS OF HYDROXYETHYLENE DIPEPTIDE ISOSTERES | EMORY UNIVERSITY (US) | 1995-06-01 | — | — | WO | disclosed |
| CN-85105797-A | The preparation of antimicrobial compounds | — | 1986-08-27 | — | — | CN | disclosed |
| EP-0160252-A2 | Antibacterial compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-06 | — | — | EP | disclosed |
| US-4474779-A | ANTIBIOTICS, BACTERICIDES | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1984-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | TP53, HIF1AN, MDM2 | ZDHHC7 2332/4885CTSS 1699/4885CTSK 2554/4885 |
| US-20120122940-A1 | POLYUNSATURATED FATTY ACIDS FOR THE TREATMENT OF DISEASES RELATED TO CARDIOVASCULAR, METABOLIC AND INFLAMMATORY DISEASE AREAS | FFAR2, FFAR3, FFAR1 | ZDHHC7 255/4885CTSS 2726/4885CTSK 3508/4885 |
| US-20260000632-A1 | STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE | GLP1R, FFAR3, IAPP | ZDHHC7 728/4885CTSS 2030/4885CTSK 3285/4885 |
| US-12358925-B2 | Targeted ubiquitination degradation BRD4 protein compound, preparation method therefor and application thereof | BRD4, SUMO1, STUB1 | ZDHHC7 214/4885CTSS 2223/4885CTSK 3487/4885 |
| US-12440466-B2 | Fatty acid derivatives for treating non-alcoholic steatohepatitis | CPT1A, NR1H2, NR1H3 | ZDHHC7 187/4885CTSS 3127/4885CTSK 2686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.